Nova Cannabis Inc.

NOVC.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NOVC.TO stands at 108M. In comparison, NBLY.TO has a market cap of 835.5M. Regarding current trading prices, NOVC.TO is priced at CA$1.74, while NBLY.TO trades at CA$18.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NOVC.TO currently has a P/E ratio of 34.80, whereas NBLY.TO's P/E ratio is -25.48. In terms of profitability, NOVC.TO's ROE is +0.06%, compared to NBLY.TO's ROE of -0.03%. Regarding short-term risk, NOVC.TO is less volatile compared to NBLY.TO. This indicates potentially lower risk in terms of short-term price fluctuations for NOVC.TO.Check NBLY.TO's competition here

NOVC.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NOVC.TO stands at 108M. In comparison, FAF.TO has a market cap of 13.1M. Regarding current trading prices, NOVC.TO is priced at CA$1.74, while FAF.TO trades at CA$0.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NOVC.TO currently has a P/E ratio of 34.80, whereas FAF.TO's P/E ratio is -0.14. In terms of profitability, NOVC.TO's ROE is +0.06%, compared to FAF.TO's ROE of -0.97%. Regarding short-term risk, NOVC.TO is less volatile compared to FAF.TO. This indicates potentially lower risk in terms of short-term price fluctuations for NOVC.TO.Check FAF.TO's competition here

NOVC.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NOVC.TO stands at 108M. In comparison, GABY.CN has a market cap of 3.7M. Regarding current trading prices, NOVC.TO is priced at CA$1.74, while GABY.CN trades at CA$0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NOVC.TO currently has a P/E ratio of 34.80, whereas GABY.CN's P/E ratio is -0.08. In terms of profitability, NOVC.TO's ROE is +0.06%, compared to GABY.CN's ROE of +2.91%. Regarding short-term risk, NOVC.TO and GABY.CN have similar daily volatility (0.00).Check GABY.CN's competition here

NOVC.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NOVC.TO stands at 108M. In comparison, IWIN.CN has a market cap of 1M. Regarding current trading prices, NOVC.TO is priced at CA$1.74, while IWIN.CN trades at CA$0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NOVC.TO currently has a P/E ratio of 34.80, whereas IWIN.CN's P/E ratio is -0.03. In terms of profitability, NOVC.TO's ROE is +0.06%, compared to IWIN.CN's ROE of -0.21%. Regarding short-term risk, NOVC.TO and IWIN.CN have similar daily volatility (0.00).Check IWIN.CN's competition here

NOVC.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NOVC.TO stands at 108M. In comparison, TREE.NE has a market cap of 1M. Regarding current trading prices, NOVC.TO is priced at CA$1.74, while TREE.NE trades at CA$0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NOVC.TO currently has a P/E ratio of 34.80, whereas TREE.NE's P/E ratio is -0.17. In terms of profitability, NOVC.TO's ROE is +0.06%, compared to TREE.NE's ROE of -4.86%. Regarding short-term risk, NOVC.TO and TREE.NE have similar daily volatility (0.00).Check TREE.NE's competition here